4D Molecular Therapeutics Inc (FDMT) — Capital Reinvestment Ratio
4D Molecular Therapeutics Inc (FDMT) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow ($28.55 Million) in capital expenditures ($631.00K). Check 4D Molecular Therapeutics Inc (FDMT) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
4D Molecular Therapeutics Inc Capital Reinvestment Ratio (2017–2017)
This chart tracks 4D Molecular Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see FDMT cash flow metrics.
Annual Capital Reinvestment Ratio for 4D Molecular Therapeutics Inc (2017–2017)
Year-by-year Capital Reinvestment Ratio for 4D Molecular Therapeutics Inc from 2017 to 2017. See FDMT FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.07x | $8.24 Million | $573.00K | — |